Tokyo, Aug. 30 (Jiji Press)–A clinical trial has demonstrated that an existing constipation drug called lubiprostone helps slow the progression of chronic kidney disease, a Japanese research team said. The finding, published in the U.S. journal Science Advances on Saturday, marks the first time the drug’s effect of maintaining renal function in humans has been demonstrated. About one in…
Tokyo, Aug. 30 (Jiji Press)–A clinical trial has demonstrated that an existing constipation drug called lubiprostone helps slow the progression of chronic kidney disease, a Japanese research team said. The finding, published in the U.S. journal Science Advances on Saturday, marks the first time the drug’s effect of maintaining renal function in humans has been demonstrated. About one in…
Leave a comment